Urgent.News

What's breaking now, across thousands of outlets.

More in Culture

Kolon Life Science Wins KLS-3021 Patent Approvals

Kolon Life Science has won official recognition in major countries for a core manufacturing process technology aimed at commercializing 'KLS-3021,' a next-generation anticancer gene therapy…

  • Kolon Life Science secured patent approvals in Korea, US, and Australia for KLS-3021 technology.
  • Patent involves mass-producing vaccinia virus using suspension cells for large-scale culture.
  • KLS-3021 is an oncolytic virus-based therapy for treating solid tumors with therapeutic genes.

More from Tuesday 27 October →